{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:32:53Z","timestamp":1759336373056},"reference-count":18,"publisher":"The Japanese Society of Nuclear Cardiology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,31]]},"DOI":"10.17996\/anc.21-00147","type":"journal-article","created":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T22:10:04Z","timestamp":1630361404000},"page":"63-66","source":"Crossref","is-referenced-by-count":1,"title":["Selective Adenosine A2A Agonists May Change Myocardial Perfusion Imaging"],"prefix":"10.17996","volume":"7","author":[{"given":"Kazuya","family":"Takehana","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Medicine II, Kansai Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7364","reference":[{"key":"1","unstructured":"1. Wolk MJ, Bailey SR, Doherty JU, et al. ACCF\/AHA\/ASE\/ASNC\/HFSA\/HRS\/SCAI\/ SCCT\/SCMR\/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Coll Cardiol 2014; 63: 380–406."},{"key":"2","unstructured":"2. Garner KK, Pomeroy W, Arnold JJ. Exercise stress testing: indications and common questions. Am Fam Physician. 2017; 96: 293–9."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Erb L, Weisman G. Coupling of P2Y receptors to G proteins and other signaling pathways. Wiley Interdiscip Rev Membr Transp Signal 2012; 1: 789–803.","DOI":"10.1002\/wmts.62"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Headrick JP, Ashton KJ, Rose'meyer RB, Peart JN. Cardiovascular adenosine receptors: expression, actions and interactions. Pharmacol Ther 2013; 140: 92–111.","DOI":"10.1016\/j.pharmthera.2013.06.002"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Zoghbi GJ, Iskandrian AE. Selective adenosine agonists and myocardial perfusion imaging. J Nucl Cardiol 2012; 19: 126–41.","DOI":"10.1007\/s12350-011-9474-9"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Fredholm BB, Chen JF, Cunha RA, Svenningsson P, Vaugeois JM. Adenosine and brain function. Int Rev Neurobiol 2005; 63: 191–270.","DOI":"10.1016\/S0074-7742(05)63007-3"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Iskandrian AE, Bateman TM, Belardinelli L, et al. Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol 2007; 14: 645–58.","DOI":"10.1016\/j.nuclcard.2007.06.114"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Cerqueira MD, Nguyen P, Staehr P, Underwood SR, Iskandrian AE; ADVANCE-MPI Trial Investigators. Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging: integrated ADVANCE-MPI trial results. JACC Cardiovasc Imaging 2008; 1: 307–16.","DOI":"10.1016\/j.jcmg.2008.02.003"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Palani G, Ananthasubramaniam K. Regadenoson: review of its established role in myocardial perfusion imaging and emerging applications. Cardiol Rev 2013; 21: 42–8.","DOI":"10.1097\/CRD.0b013e3182613db6"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Lieu HD, Shryock JC, von Mering GO, et al. Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans. J Nucl Cardiol 2007; 14; 514–20.","DOI":"10.1016\/j.nuclcard.2007.02.016"},{"key":"11","unstructured":"11. Astellas Pharma US, Inc. Lexiscan [package insert]. Northbrook, IL; 2018. https:\/\/www.astellas.us\/docs\/lexiscan.pdf"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Brink HL, Dickerson JA, Stephens JA, Pickworth KK. Comparison of the safety of adenosine and regadenoson in patients undergoing outpatient cardiac stress testing. Pharmacotherapy 2015; 35: 1117–23.","DOI":"10.1002\/phar.1669"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Page RL 2nd, Spurck P, Bainbridge JL, Michalek J, Quaife RA. Seizures associated with regadenoson: a case series. J Nucl Cardiol 2012; 19: 389–91.","DOI":"10.1007\/s12350-011-9461-1"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Rosenblatt J, Mooney D, Dunn T, Cohen M. Asystole following regadenoson infusion in stable outpatients. J Nucl Cardiol 2014; 21: 862–8.","DOI":"10.1007\/s12350-014-9898-0"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Platsman Z, Auerbach A, Lee A, Jauhar R, Makaryus JN. Regadenoson-induced coronary vasospasm resulting in severe reversible perfusion defects and transient ischemic dilation on SPECT stress myocardial perfusion imaging. J Nucl Cardiol 2016; 23: 843–5.","DOI":"10.1007\/s12350-015-0275-4"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Glover DK, Ruiz M, Takehana K, et al. Pharmacological stress myocardial perfusion imaging with the potent and selective A2A adenosine receptor agonists ATL193 and ATL146e administered by either intravenous infusion or bolus injection. Circulation 2001; 104: 1181–7.","DOI":"10.1161\/hc3601.093983"},{"key":"17","unstructured":"17. Takehana K, Beller GA, Ruiz M, Petruzella FD, Watson DD, Glover DK. Assessment of residual coronary stenoses using 99m<\/sup>Tc-N-NOET vasodilator stress imaging to evaluate coronary flow reserve early after coronary reperfusion in a canine model of infarction. J Nucl Med 2001; 42: 1388–94."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. The American Society of Nuclear Cardiology. 2013 Nuclear cardiology trend survey. J Nucl Cardiol 2014; 21: S5–88.","DOI":"10.1007\/s12350-014-9862-z"}],"container-title":["Annals of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/anc\/7\/1\/7_21-00147\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T03:47:43Z","timestamp":1630727263000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/anc\/7\/1\/7_21-00147\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,31]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.17996\/anc.21-00147","relation":{},"ISSN":["2189-3926","2424-1741"],"issn-type":[{"value":"2189-3926","type":"print"},{"value":"2424-1741","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,31]]},"article-number":"21-00147"}}